|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 针刺临床试验干预措施报告标准修订版:CONSORT声明的扩展显示文摘'针刺临床试验干预措施报告标准'(Standards,for Reporting Interventions in Clinical Trials of Acupuncture,STRICTA)于2001年和2002年在5种期刊上发表。该指南以对照试验检查清单及解释的形式供作者和期刊编辑使用,旨在提高针刺临床试验报告的质量,尤其是对其中干预措施的报告,因而有助于对这些试验的解释和重复。随后对STRICTA的应用及影响的述评都强调了STRICTA的价值,也提出了改进和修订的建议。为使修订过程顺利进地,STRICTA工作组、CONSORT工作组和中国Cochrane中心于2008年开始合作,召集成立的包含47名成员的专家小组对清单的修改稿提出了电子版反馈意见。在后来于弗莱堡(Freiburg)召开的见面会上,由21名专家组成的工作组进一步修订了STRICTA对照检查清单,并计划如何对其进行发布。新的STRICTA对照检查清单作为CONSORT的正式扩展版,包含6项条目及17条二级条目。这些条目为报告针刺治疗的合理性、针刺的细节、治疗方案、其他干预措施、治疗师的背景以及对照或对照干预提供了指南。而且,作为修订工作的一部分,对每一条目作了详尽解释,并针对每一条目给出了良好报告的实例。此外,STRICTA中的'对照'(controlled)一词被替换成了'临床'(clinical),以示STRICTA适用于更广泛的各类临床评价设计,包括非对照结局研究和病例报道。修订的STRICTA对照检查清单有望与CONSORT声明及其非药物治疗扩展版一起共同提高针刺临床试验的报告质量。 | Hugh MacPherson Douglas G.Altman Richard Hammerschlag 李幼平 吴泰相 Adrian White David Moher 代表STRICTA修订版工作组 刘建平 | 2010 | 中国循证医学杂志2010，10，10： | 126 |
| 2 | 针刺临床试验干预措施报告标准的修订:CONSORT声明的扩展显示文摘'针刺临床试验干预措施报告标准'(STandards for Reporting Interventions in Clinical Trials of Acupuncture,STRICTA)于2001年和2002年在5种期刊上发表。该指南以对照检查清单及解释的形式供作者和期刊编辑使用,旨在提高针刺临床试验报告的质量,尤其是对其中干预措施的报告,因而有助于对这些试验的解释和重复。随后对STRICTA的应用及影响的述评都强调了STRICTA的价值,也提出了改进和修订的建议。为使修订过程顺利进行,STRICTA工作组、CONSORT工作组和中国Cochrane中心于2008年开始合作。召集成立的有47名成员的专家组对清单的修改稿提出了电子版反馈意见。在后来于弗莱堡(Freiburg)召开的见面会上,由21名专家组成的工作组进一步修订了STRICTA对照检查清单,并计划如何对其进行发布。新的STRICTA对照检查清单作为CONSORT的正式扩展版,包含6项条目及17条二级条目。这些条目为报告针刺治疗的合理性、针刺的细节、治疗方案、其他干预措施、治疗师的背景以及对照或对照干预提供了指南。而且,作为修订工作的一部分,对每一条目作了详尽解释,并针对每一条目给出了报告良好的实例。此外,STRICTA中的'对照'(controlled)一词被替换成了'临床'(clinical),以示STRICTA适用于更广泛的各类临床评价设计,包括非对照结局研究和病例报道。修订的STRICTA对照检查清单有望与CONSORT声明及其非药物治疗扩展版一起共同提高针刺临床试验的报告质量。 | Hugh MacPherson Douglas G Altman Richard Hammerschlag 李幼平 吴泰相 Adrian White David Moher 刘建平 | 2010 | 中西医结合学报2010，8，9： | 33 |
| 3 | 新西兰苹果品种及砧木育种成就与对中国的启示显示文摘20世纪60年代新西兰的Don Mc Kenzie博士从果农J.H.Kidd配置的杂交后代中选出了世界级的苹果品种‘嘎拉’。随后,新西兰植物与食品研究所于80年代初期开始了持续专业的苹果育种研究,先后培育出了一系列优良的世界性品种。苹果育种技术也从常规育种进入了分子育种时代,一跃成为世界苹果育种强国,吸引了世界众多果树科研单位和育种者争相学习其先进技术和科研成果。为了进一步提升中国苹果育种水平,缩小与苹果育种强国的差距,作者系统的介绍了新西兰的苹果品种和砧木选育的发展历程、选育方法,特别是生物技术在新品种选育中的应用,并对比分析目前中国苹果品种及砧木选育的方法,提出中国苹果育种方法的改进建议,希望对中国的苹果育种工作有所启发。 | 张恒涛 BUS Vincent G.M. WHITE Allan G. 阎振立 过国南 张瑞萍 刘珍珍 YAO Jia-long CHAGNE David | 2016 | 果树学报2016，33，4： | 5 |
| 4 | A history of high-power laser research and development in the United Kingdom显示文摘The first demonstration of laser action in ruby was made in 1960 by T.H.Maiman of Hughes Research Laboratories,USA.Many laboratories worldwide began the search for lasers using different materials,operating at different wavelengths.In the UK,academia,industry and the central laboratories took up the challenge from the earliest days to develop these systems for a broad range of applications.This historical review looks at the contribution the UK has made to the advancement of the technology,the development of systems and components and their exploitation over the last 60 years. | Colin N.Danson Malcolm White John R.M.Barr Thomas Bett Peter Blyth David Bowley Ceri Brenner Robert J.Collins Neal Croxford A.E.Bucker Dangor Laurence Devereux Peter E.Dyer Anthony Dymoke-Bradshaw Christopher B.Edwards Paul Ewart Allister I.Ferguson John M.Girkin Denis R.Hall David C.Hanna Wayne Harris David I.Hillier Christopher J.Hooker Simon M.Hooker Nicholas Hopps Janet Hull David Hunt Dino A.Jaroszynski Mark Kempenaars Helmut Kessler Sir Peter L.Knight Steve Knight Adrian Knowles Ciaran L.S.Lewis Ken S.Lipton Abby Littlechild John Littlechild Peter Maggs Graeme P.A.Malcolm OBE Stuart P.D.Mangles William Martin Paul McKenna Richard O.Moore Clive Morrison Zulfikar Najmudin David Neely Geoff H.C.New Michael J.Norman Ted Paine Anthony W.Parker Rory R.Penman Geoff J.Pert Chris Pietraszewski Andrew Randewich Nadeem H.Rizvi Nigel Seddon MBE Zheng-Ming Sheng David Slater Roland A.Smith Christopher Spindloe Roy Taylor Gary Thomas John W.G.Tisch Justin S.Wark Colin Webb S.Mark Wiggins Dave Willford Trevor Winstone | 2021 | High Power Laser Science and Engineering2021，9，2： | 5 |
| 5 | DMP1 prevents osteocyte alterations,FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease显示文摘During chronic kidney disease (CKD),alterations in bone and mineral metabolism include increased production of the hormone fibroblast growth factor 23 (FGF23) that may contribute to cardiovascular mortality.The osteocyte protein dentin matrix protein 1 (DMP1) reduces FGF23 and enhances bone mineralization,but its effects in CKD are unknown.We tested the hypothesis that DMP1 supplementation in CKD would improve bone health,prevent FGF23 elevations and minimize consequent adverse cardiovascular outcomes.We investigated DMP1 regulation and effects in wild-type (WT) mice and the Col4a3^-/- mouse model of CKD.Col4a3^-/- mice demonstrated impaired kidney function,reduced bone DMP1 expression,reduced bone mass,altered osteocyte morphology and connectivity,increased osteocyte apoptosis,increased serum FGF23,hyperphosphatemia,left ventricular hypertrophy (LVH),and reduced survival.Genetic or pharmacological supplementation of DMP1 in Col4a3^-/- mice prevented osteocyte apoptosis,preserved osteocyte networks,corrected bone mass,partially lowered FGF23 levels by attenuating NFAT-induced FGF23 transcription,and further increased serum phosphate.Despite impaired kidney function and worsened hyperphosphatemia,DMP1 prevented development of LVH and improved Col4a3^-/- survival.Our data suggest that CKD reduces DMP1 expression,whereas its restoration represents a potential therapeutic approach to lower FGF23 and improve bone and cardiac health in CKD. | Corey Dussold Claire Gerber Samantha White Xueyan Wang Lixin Qi Connor Francis Maralee Capella Guillaume Courbon Jingya Wang Chaoyuan Li Jian Q. Feng Tamara Isakova Myles Wolf Valentin David Aline Martin | 2019 | Bone Research2019，7，2： | 4 |
| 6 | IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030显示文摘 | David R. Whiting Leonor Guariguata Clara Weil Jonathan Shaw | 2011 | Diabetes Research and Clinical Practice2011，，3： | 4 |
| 7 | Scientific evidence is just the starting point: A generalizable process for developing sports injury prevention interventions显示文摘Background: The 2 most cited sports injury prevention research frameworks incorporate intervention development, yet little guidance is available in the sports science literature on how to undertake this complex process. This paper presents a generalizable process for developing implementable sports injury prevention interventions, including a case study applying the process to develop a lower limb injury prevention exercise training program(Footy First) for community Australian football.Methods: The intervention development process is underpinned by 2 complementary premises:(1) that evidence-based practice integrates the best available scientific evidence with practitioner expertise and end user values and(2) that research evidence alone is insufficient to develop implementable interventions.Results: The generalizable 6-step intervention development process involves(1) compiling research evidence, clinical experience, and knowledge of the implementation context;(2) consulting with experts;(3) engaging with end users;(4) testing the intervention;(5) using theory; and(6)obtaining feedback from early implementers. Following each step, intervention content and presentation should be revised to ensure that the final intervention includes evidence-informed content that is likely to be adopted, properly implemented, and sustained over time by the targeted intervention deliverers. For Footy First, this process involved establishing a multidisciplinary intervention development group, conducting 2targeted literature reviews, undertaking an online expert consensus process, conducting focus groups with program end users, testing the program multiple times in different contexts, and obtaining feedback from early implementers of the program.Conclusion: This systematic yet pragmatic and iterative intervention development process is potentially applicable to any injury prevention topic across all sports settings and levels. It will guide researchers wishing to undertake intervention development. | Alex Donaldson David G.Lloyd Belinda J.Gabbe Jill Cook Warren Young Peta White Caroline F.Finch | 2016 | Journal of Sport and Health Science2016，5，3： | 3 |
| 8 | Dysregulation of Wnt/β-Catenin Signaling in Gastrointestinal Cancers显示文摘 | Bryan D. White Andy J. Chien David W. Dawson | 2012 | Gastroenterology2012，，： | 2 |
| 9 | CD133 expression is not restricted to stem cells, and both CD133^sup +^ and CD133^sup -^ metastatic colon cancer cells initiate tumors显示文摘 | Shmelkov Sergey V Butler Jason M Hooper Andrea T Hormigo Adilia Kushner Jared Milde Till Clair Ryan St Baljevic Muhamed White Ian Jin David K Chadburn Amy Murphy Andrew J Valenzuela David M Gale Nicholas W Thurston Gavin Yancopoulos George | 2008 | Journal of Clinical Investigation2008，，： | 2 |
| 10 | Restore or retreat? Saltwater intrusion and water management in coastal wetlands显示文摘Coastal wetlands perform a unique set of physical,chemical,and biological functions,which provide billions of dollars of ecosystem services annually.These wetlands also face myriad environmental and anthropogenic pressures,which threaten their ecological condition and undermine their capacity to provide these services.Coastal wetlands have adapted to a dynamic range of natural disturbances over recent millennia,but face growing pressures from human population growth and coastal development.These anthropogenic pressures are driving saltwater intrusion(SWI)in many coastal systems.The position of coastal wetlands at the terrestrial-marine interface also makes them vulnerable to increasing rates of sealevel rise and changing climate.Critically,anthropogenic and natural stressors to coastal wetlands can act synergistically to create negative,and sometimes catastrophic,consequences for both human and natural systems.This review focused on the drivers and impacts of SWI in coastal wetlands and has two goals:(1)to synthesize understanding of coastal wetland change driven by SWI and(2)to review approaches for improved water management to mitigate SWI in impacted systems.While we frame this review as a choice between restoration and retreat,we acknowledge that choices about coastal wetland management are context-specific and may be confounded by competing management goals.In this setting,the choice between restoration and retreat can be prioritized by identifying where the greatest return in ecosystem services can be achieved relative to restoration dollars invested.We conclude that restoration and proactive water management is feasible in many impacted systems. | Elliott White,Jr. David Kaplan | 2017 | Ecosystem Health and Sustainability2017，3，1： | 2 |
| 11 | Dexmedetomidine Infusion During Laparoscopic Bariatric Surgery: The Effect on Recovery Outcome Variables显示文摘 | Burcu Tufanogullari Paul F. White Mariana P. Peixoto Daniel Kianpour Thomas Lacour James Griffin Gary Skrivanek Amy Macaluso Mary Shah David A. Provost | 2008 | Anesthesia & Analgesia2008，，6： | 2 |
| 12 | ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance显示文摘 | W. Gregory Hundley David A. Bluemke J. Paul Finn Scott D. Flamm Mark A. Fogel Matthias G. Friedrich Vincent B. Ho Michael Jerosch-Herold Christopher M. Kramer Warren J. Manning Manesh Patel Gerald M. Pohost Arthur E. Stillman Richard D. White Pamela K. Wo | 2010 | Journal of the American College of Cardiology2010，，23： | 1 |
| 13 | Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research显示文摘 | David A. Calhoun Daniel Jones Stephen Textor David C. Goff Timothy P. Murphy Robert D. Toto Anthony White William C. Cushman William White Domenic Sica Keith Ferdinand Thomas D. Giles Bonita Falkner Robert M. Carey | 2008 | Hypertension2008，，6： | 1 |
| 14 | Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research显示文摘 | David A. Calhoun Daniel Jones Stephen Textor David C. Goff Timothy P. Murphy Robert D. Toto Anthony White William C. Cushman William White Domenic Sica Keith Ferdinand Thomas D. Giles Bonita Falkner Robert M. Carey | 2008 | Hypertension2008，，6： | 1 |
| 15 | Detection, evaluation, and treatment of severe and resistant hypertension显示文摘 | William B. White J. Rick Turner Domenic A. Sica John D. Bisognano David A. Calhoun Raymond R. Townsend Herbert D. Aronow Deepak L. Bhatt George L. Bakris | 2014 | Journal of the American Society of Hypertension2014，，10： | 1 |
| 16 | Role of p38 mitogen-actived protein kinase in cardiac myocyte secretion of the inflammatory cytokine TNF-α显示文摘 | Ballard -Croft CD White J David L | 2001 | Am J Physiol Heart Cire Physiol2001，280，： | 1 |
| 17 | Association of Aspirin Dose and Vorapaxar Safety and Efficacy in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome (From the TRACER Trial)显示文摘 | Kenneth W. Mahaffey Zhen Huang Lars Wallentin Robert F. Storey Lisa K. Jennings Pierluigi Tricoci Harvey D. White Paul W. Armstrong Philip E. Aylward David J. Moliterno Frans Van de Werf Edmond Chen Sergio Leonardi Tyrus Rorick Claes Held John Strony Robe | 2013 | The American Journal of Cardiology2013，，： | 1 |
| 18 | Sleep Apnea and Cardiovascular Disease显示文摘 | Virend K. Somers David P. White Raouf Amin William T. Abraham Fernando Costa Antonio Culebras Stephen Daniels John S. Floras Carl E. Hunt Lyle J. Olson Thomas G. Pickering Richard Russell Mary Woo Terry Young | 2008 | Journal of the American College of Cardiology2008，，8： | 1 |
| 19 | Effects of Extracorporeal Shock Wave Therapy on Bone显示文摘 | Scott R. Mcclure David Van sickle M. Randy White | | 0，，01： | 1 |
| 20 | Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: Insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER)显示文摘 | William Schuyler Jones Pierluigi Tricoci Zhen Huang David J. Moliterno Robert A. Harrington Peter R. Sinnaeve John Strony Frans Van de Werf Harvey D. White Claes Held Paul W. Armstrong Philip E. Aylward Edmond Chen Manesh R. Patel Kenneth W. Mahaffey | 2014 | American Heart Journal2014，，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员